Document:

Nonqualified Stock Option Agreement

  
 Exhibit 10.2

  
 SERACARE LIFE SCIENCES, INC. 
 NONQUALIFIED STOCK OPTION AGREEMENT 
  
 THIS NONQUALIFIED STOCK OPTION AGREEMENT (this “Option Agreement”) by and between SeraCare Life Sciences, Inc. a California
corporation (the “Corporation”), and Thomas Lawlor (the “Participant”) evidences the nonqualified stock option (the “Option”) granted by the Corporation to the Participant as to the number of shares
of the Corporation’s common stock, no par value (the “Common Stock”), first set forth below. 
  

					
	 Number of Shares of Common Stock:1
	  	160,000	  	Award Date: December 13, 2004
			
	 Exercise Price per Share:1
	  	$11.54	  	Expiration Date:1,2 December 13,
2010
	
	Vesting1,2 One-third of the total
number of shares subject to the Option shall vest on each of the first, second and third anniversaries of the Award Date.

  
 The Option is subject
to the Terms and Conditions of Option (the “Terms”) attached to this Option Agreement (incorporated herein by this reference). The Option has been granted to the Participant in addition to, and not in lieu of, any other form of
compensation otherwise payable or to be paid to the Participant. The Option is not and shall not be deemed to be an incentive stock option within the meaning of Section 422 of the U.S. Internal Revenue Code of 1986, as amended (the
“Code”). The parties agree to the terms of the Option set forth herein, and the Participant acknowledges receipt of a copy of the Terms. 
  

									
	“PARTICIPANT”	 	 	 	 “SERACARE LIFE SCIENCES, INC.”
 (a California corporation)

				
	/s/ Thomas Lawlor	 	 	 	 By:
	 	/s/ Michael F. Crowley, Jr.
	Signature	 	 	 	 	 	 
				
	 Thomas Lawlor
	 	 	 	 Its:
	 	Chief Executive Officer
	Print Name	 	 	 	 	 	 
				
	 66 Old North Trail
	 	 	 	 	 	 
	Address	 	 	 	 	 	 
				
	 Mansfield, Massachusetts 02049
	 	 	 	 	 	 
	City, State, Zip Code	 	 	 	 	 	 

  
 CONSENT OF SPOUSE

  
 In consideration of the Corporation’s execution of
this Option Agreement, the undersigned spouse of the Participant agrees to be bound by all of the terms and provisions hereof, including the Terms. 
  

					
	  	 	 	 	  
	Signature of Spouse	 	 	 	Date

	1	Subject to adjustment under Section 4.1 of the Terms. 

	2	Subject to early termination under Section 4.2 or 4.3 of the Terms. 

 

 TERMS AND CONDITIONS OF OPTION 
  
 1. Vesting; Limits on Exercise. 
  
 As set forth in the Option Agreement, the Option shall vest and become exercisable in percentage installments of the aggregate number of shares of Common
Stock subject to the Option. The Option may be exercised only to the extent the Option is vested and exercisable. 
  

	 	•	Cumulative Exercisability. To the extent that the Option is vested and exercisable, the Participant has the right to exercise the Option (to the extent not previously
exercised), and such right shall continue, until the expiration or earlier termination of the Option. 

  

	 	•	No Fractional Shares. Fractional share interests shall be disregarded, but may be cumulated. 

  

	 	•	Minimum Exercise. No fewer than 1001
shares of Common Stock may be purchased at any one time, unless the number purchased is the total number at the time exercisable under the Option. 

  

2. Continuance of Employment Required; No Employment Commitment. 
  
 The vesting schedule requires continued service through each applicable vesting date as a condition to the vesting of the
applicable installment of the Option and the rights and benefits under this Option Agreement. Partial service, even if substantial, during any vesting period will not entitle the Participant to any proportionate vesting or avoid or mitigate a
termination of rights and benefits upon or following a termination of employment or services as provided in Section 4.3 below. 
  
 Nothing contained in this Option Agreement constitutes an employment commitment by the Corporation, confers upon the Participant any right to remain
employed by the Corporation or any Subsidiary, interferes in any way with the right of the Corporation or any Subsidiary at any time to terminate such employment, or affects the right of the Corporation or any Subsidiary to increase or decrease the
Participant’s other compensation. 
  
 For purposes of this
Option Agreement, “Subsidiary” means any corporation or other entity a majority of whose outstanding voting stock or voting power is beneficially owned directly or indirectly by the Corporation. 
  
 3. Exercise of Option. 
  
 3.1. Method of Exercise. The Option shall be exercisable by the
delivery to the Secretary of the Corporation of a written notice stating the number of shares of Common Stock to be purchased pursuant to the Option and accompanied by: 
  

	 	•	delivery of an executed Exercise Agreement in substantially the form attached hereto as Exhibit A or such other form as from time to time may be required by the Corporation (the
“Exercise Agreement”); 

  

 1 

	 	•	payment in full for the Exercise Price of the shares to be purchased in one of the forms set forth under Section 3.2; 

  

	 	•	satisfaction of the tax withholding provisions of Section 3.3 below; and 

  

	 	•	any written statements or agreements required pursuant to Section 3.4 below. 

  

3.2. Payment of Exercise Price. The Exercise Price of the shares to be purchased will be paid in full at the time of each purchase in one or a
combination of the following methods: 
  

	 	•	in cash or by electronic funds transfer; 

  

	 	•	by check payable to the order of the Corporation; 

  

	 	•	if authorized by the Corporation, by a cashless exercise pursuant to such rules as the Corporation may adopt; 

  

	 	•	by notice and third party payment in such manner as may be authorized by the Corporation; 

  

	 	•	subject to the proviso below and the approval of the Corporation’s Board of Directors (the “Board”) at the time, by the delivery of shares of Common Stock
already owned by the Participant, provided that any shares of Common Stock delivered that were initially acquired from the Corporation upon exercise of a stock option must have been owned by the Participant at least six (6) months as of the date of
delivery. 

  
 Shares of Common Stock used to satisfy the Exercise
Price will be valued at their Fair Market Value on the date of exercise. “Fair Market Value” on any date means: 
  

	 	(a)	if the stock is listed or admitted to trade on a national securities exchange, the closing price of the stock on the Composite Tape, as published in the Western Edition of The Wall
Street Journal, of the principal national securities exchange on which the stock is so listed or admitted to trade, on such date, or, if there is no trading of the stock on such date (or if the market has not closed at the applicable time), then the
closing price of the stock as quoted on such Composite Tape on the next preceding date on which there was trading in such shares; 

  

	 	(b)	if the stock is not listed or admitted to trade on a national securities exchange, the last price for the stock, as furnished by the National Association of Securities Dealers, Inc.
(“NASD”) through the NASDAQ National Market Reporting System or a similar organization if the NASD is no longer reporting such information, on such date, or, if there is no trading of the stock on such date (or if the market has not
closed at the applicable time), then the last price of the stock as so furnished on the next preceding date on which there was trading in such shares; or 

  

	 	(c)	 if the stock is not listed or admitted to trade on a national securities exchange and is not reported by the NASD through the NASDAQ National Market Reporting
System or a similar organization if the NASD 

  

 2 

	 	 
is no longer reporting such information, the value as established by the Corporation at such time for purposes of this Option Agreement (if the price of the
stock is furnished by the NASD through the NASDAQ SmallCap Market, the Corporation’s determination of Fair Market Value may be based on, without limitation, the last price and/or the mean between the bid and asked prices for the stock as of the
relevant date or as of the last date that there was trading in the stock, as applicable). 

  
 3.3. Tax Withholding. Upon any exercise, vesting, or payment of the Option, the Corporation shall have the right at its option to: 
  

	 	•	require the Participant (or his personal representative or his beneficiary, in the case of the Participant’s disability or death, as the case may be) to pay or provide for
payment of at least the minimum amount of any taxes which the Corporation may be required to withhold with respect to the Option event or payment; 

  

	 	•	deduct from any amount payable in cash the minimum amount of any taxes which the Corporation may be required to withhold with respect to such cash payment; or

  

	 	•	reduce the number of shares of Common Stock to be delivered by (or otherwise reacquire) the appropriate number of shares of Common Stock, valued at their then Fair Market Value, to
satisfy such withholding obligation. 

  
 In no event will the value
of any shares withheld exceed the minimum amount of required withholding under applicable law. 
  
 3.4. Legal Compliance. The grant of the Option and the offer, issuance and delivery of shares of Common Stock in respect of the Option are subject to compliance with all applicable federal and state laws, rules
and regulations (including but not limited to state and federal securities law, federal margin requirements) and to such approvals by any listing, regulatory or governmental authority as may, in the opinion of counsel for the Corporation, be
necessary or advisable in connection therewith. In addition, any securities delivered in respect of the Option may be subject to any special restrictions to preserve a pooling of interests under generally accepted accounting principles. The person
acquiring any securities in respect of the Option will, if requested by the Corporation, provide such assurances and representations to the Corporation as the Corporation may deem necessary or desirable to assure compliance with all applicable legal
and accounting requirements. 
  
 4. Adjustments; Early Termination.

  
 4.1. Adjustments. Upon or in contemplation of any
reclassification, recapitalization, stock split (including a stock split in the form of a stock dividend) or reverse stock split; any merger, combination, consolidation, or other reorganization; any spin-off, split-up, or similar extraordinary
dividend distribution (“spin-off”) in respect of the Common Stock (whether in the form of securities or property); any exchange of Common Stock or other securities of the Corporation, or any similar, unusual or extraordinary corporate
transaction in respect of the Common Stock; or a sale of all or substantially all the assets of the Corporation as an entirety (“asset sale”); then the 

  

 3 

 
Corporation shall, in such manner, to such extent (if any) and at such time as it deems appropriate and equitable in the circumstances: 
  

	 	(a)	in any of such events, proportionately adjust any or all of (i) the number of shares of Common Stock or the number and type of other securities that thereafter may be made the
subject of the Option, and (ii) the Exercise Price of the Option, or 

  

	 	(b)	in the case of a reclassification, recapitalization, merger, consolidation, combination, or other reorganization, spin-off or asset sale, make provision for a cash payment or for
the substitution or exchange of the Option or the cash, securities or property deliverable to the Participant based upon the distribution or consideration payable to holders of the Common Stock upon or in respect of such event.

  
 The Corporation may adopt such valuation
methodologies with respect to the Option as it deems reasonable in the event of a cash or property settlement, including without limitation basing such settlement solely upon the excess if any of the per share amount payable upon or in respect of
such event over the Exercise Price. 
  
 In any of such events, the
Corporation may take such action prior to such event to the extent that the Corporation deems the action necessary to permit the Participant to realize the benefits intended to be conveyed with respect to the underlying shares in the same manner as
is or will be available to stockholders generally. 
  
 4.2.
Possible Early Termination of Option. Reference is made to that certain Key Executive Employment Agreement, with an effective date of December 13, 2004, by and between the Corporation and the Participant (the “Employment
Agreement”). As provided in Section 7(b) of the Employment Agreement, if a “Change in Control” (as such term is defined in the Employment Agreement) occurs, the unvested portion of the Option shall immediately become fully vested.
To the extent the Option is vested and not exercised in connection with or prior to (a) a dissolution of the Corporation, (b) an event described in Section 4.1 that the Corporation does not survive, or (c) the consummation of a Change in Control,
the Option shall terminate, subject to any provision that has been made by the Corporation through a plan of reorganization or otherwise for the substitution, assumption, exchange or other settlement of the Option. 
  
 4.3. Effects of Termination of Employment or Service. If the
Participant is terminated by the Corporation for any reason other than “Cause” (as such term is defined in the Employment Agreement) or if the Participant terminates his employment for “Good Reason” (as such term is defined in
the Employment Agreement) (the date of the Participant’s termination is referred to herein as the “Severance Date”), the portion, if any, of the Option that would have vested during the remainder of the calendar year in which
the termination occurs shall immediately become fully vested and the Participant shall have three (3) months after the Severance Date to exercise the Option to the extent it shall be or shall have become exercisable on the Severance Date. In the
case of a termination for Cause, the Option shall terminate on the Severance Date. In all other cases, the Option, to the extent not exercisable on the Severance Date, shall terminate. 
  
 Notwithstanding any other provision herein, the Option shall not continue to vest during any leave of absence of the
Participant, unless the Corporation otherwise 

  

 4 

 
expressly provides in connection with the leave or unless continued vesting is required as a matter of law in respect of the nature of the leave. 

 
 5. Non-Transferability and Other Restrictions. The Option and any
other rights of the Participant under this Option Agreement are nontransferable and exercisable only by the Participant, except as set forth below. 
  
 The exercise and transfer restrictions set forth above will not apply to: 
  

	 	•	transfers to the Corporation, 

  

	 	•	the designation of a beneficiary to receive benefits in the event of the Participant’s death or, if the Participant has died, transfers to or exercise by the Participant’s
beneficiary, or, in the absence of a validly designated beneficiary, transfers by will or the laws of descent and distribution, 

  

	 	•	transfers pursuant to a qualified domestic relations order if approved or ratified by the Corporation, 

  

	 	•	if the Participant has suffered a disability, permitted transfers or exercises on behalf of the Participant by his legal representative, 

  

	 	•	the authorization by the Corporation of “cashless exercise” procedures consistent with applicable laws and the express authorization of the Corporation, or

  

	 	•	upon approval by the Corporation, transfers to certain persons or entities related to the Participant, subject to the condition that the Corporation receive evidence satisfactory to
it that the transfer is being made for essentially estate and/or tax planning purposes on a gratuitous or donative basis and without consideration (other than nominal consideration or in exchange for an interest in a qualified transferee).

  
 6. Privileges of Stock Ownership. 
  
 Except as otherwise expressly authorized by the Corporation, the Participant
shall not be entitled to any privilege of stock ownership as to any shares of Common Stock not actually delivered to and held of record by the Participant. No adjustment will be made for dividends or other rights as a shareholder for which a record
date is prior to such date of delivery. 
  
 7. No Corporate Action
Restriction. 
  
 The existence of the Option and
this Option Agreement shall not limit, affect or restrict in any way the right or power of the Board or the shareholders of the Corporation to make or authorize: (a) any adjustment, recapitalization, reorganization or other change in the
Corporation’s or any Subsidiary’s capital structure or its business, (b) any merger, amalgamation, consolidation or change in the ownership of the Corporation or any subsidiary, (c) any issue of bonds, debentures, capital, preferred or
prior preference stock ahead of or affecting the Corporation’s or any Subsidiary’s capital stock or the rights thereof, (d) any dissolution or liquidation of the Corporation or any Subsidiary, (e) any sale or transfer of all or any part of
the Corporation or any Subsidiary’s assets or 

  

 5 

 
business, or (f) any other corporate act or proceeding by the Corporation or any Subsidiary. Neither the Participant nor any other person shall have any
claim under the Option or this Option Agreement against any member of the Board, or the Corporation or any employees, officers or agents of the Corporation or any Subsidiary, as a result of any such action. 
  
 8. Notices. 
  
 Any notice to be given under the terms of this Option Agreement or the Exercise Agreement shall be in writing and addressed
to the Corporation at its principal office to the attention of the Secretary, and to the Participant at the address given beneath the Participant’s signature hereto, or at such other address as either party may hereafter designate in writing to
the other. Any such notice shall be given only when received, but if the Participant is no longer employed by the Corporation or any Subsidiary, shall be deemed to have been duly given when enclosed in a properly sealed envelope addressed as
aforesaid, registered or certified, and deposited (postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government. 
  
 9. Entire Agreement. 
  
 This Option Agreement (together with the form of Exercise Agreement attached
hereto) constitutes the entire agreement and supersedes all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof. This Option Agreement and the Exercise Agreement may be amended only
by a written instrument signed by both the Participant and the Corporation. The Corporation may, however, unilaterally waive any provision hereof or of the Exercise Agreement in writing to the extent such waiver does not adversely affect the
interests of the Participant hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof. 
  
 10. Governing Law; Limited Rights. 
  

10.1. California Law. This Option Agreement shall be governed by and construed and enforced in accordance with the laws of the State of
California without regard to conflict of law principles thereunder. 
  
 10.2. Limited Rights. The Participant has no rights as a shareholder of the Corporation with respect to the Option as set forth in Section 6. The Option does not place any limit on the corporate authority of the Corporation as set
forth in Section 7. 
  
 11. Representations by the Participant.

  
 The Participant by executing this Option Agreement hereby
makes the following representations to the Corporation and acknowledges that the Corporation’s reliance on securities law exemptions from qualification in the State of California is predicated, in substantial part, upon the accuracy of these
representations: 
  

	 	•	 The Participant is acquiring the Option and if and when he exercises the Option will acquire the shares of Common Stock solely for the Participant’s own
account, for investment purposes only, and not with a view to or an intent to sell, or to offer for resale in connection with any unregistered distribution, 

  

 6 

	 	 
all or any portion of the shares within the meaning of the Securities Act of 1933, as amended, the California Corporate Securities Law, or other applicable
state securities laws. 

  

	 	•	The Participant is knowledgeable about the Corporation and has a preexisting personal or business relationship with the Corporation. As a result of such relationship, he is familiar
with, among other characteristics, its business and financial circumstances and has access on a regular basis to or may request the Corporation’s condensed consolidated balance sheet and condensed consolidated income statement setting forth
information material to the Corporation’s financial condition, operations and prospects. 

  

	 	•	At no time was an oral representation made to the Participant relating to the Option or the purchase of shares of Common Stock and the Participant was not presented with or
solicited by any promotional meeting or material relating to the Option or the Common Stock. 

  
 (Remainder of Page Intentionally Left Blank) 
  

 7 

  
 EXHIBIT A

  
 SERACARE LIFE SCIENCES, INC. 
 OPTION EXERCISE AGREEMENT 
  
 The undersigned (the “Purchaser”) hereby irrevocably elects to exercise his right, evidenced by that certain Nonqualified Stock Option
Agreement dated as of                              (the “Option Agreement”), as
follows: 
  

	 	•	the Purchaser hereby irrevocably elects to purchase
                             shares of Common Stock, no par value per share (the
“Shares”), of SeraCare Life Sciences, Inc., a California corporation (the “Corporation”), and 

  

	 	•	such purchase shall be at the price of $                     per share,
for an aggregate amount of $                     (subject to applicable withholding taxes pursuant to Section 3.3 of the Terms and Conditions
of Option attached to the Option Agreement (the “Terms”)). 

  
 Delivery of Share Certificate. The Purchaser requests that a certificate representing the Shares be registered to Purchaser and delivered to:
                                        
                                        
                                        
                                     
  
 __________________________________________________________________________________________________________. 
  
 Option Agreement. The Purchaser acknowledges that all of his rights are subject to, and the Purchaser agrees to be bound by, all of the terms and
conditions of the Option Agreement, which is incorporated herein by this reference. If a conflict or inconsistency between the terms and conditions of this Exercise Agreement and of the Option Agreement shall arise, the terms and conditions of the
Option Agreement shall govern. The Purchaser acknowledges receipt of a copy of all documents referenced herein and acknowledges reading and understanding these documents and having an opportunity to ask any questions that he may have had about them.

  

									
	“PURCHASER”	 	 	 	ACCEPTED BY:
	 	 	 	 	 SERACARE LIFE SCIENCES, INC.
 (a
California corporation)

	Signature	 	 	 	 	 	 
	 	 	 	 	 By:
	 	 
	 	 	 	 	 	 	 
	Print Name	 	 	 	 	 	 
				
	 	 	 	 	 Print Name:
	 	 
	Address	 	 	 	 	 	 
	 	 	 	 	 Title:
	 	 
			
	 	 	 	 	(To be completed by the Corporation after the price (including applicable withholding taxes), value (if applicable) and receipt of funds is
verified.)
	City, State, Zip Code	 	 	 

  

 1REGISTRATION RIGHTS AGREEMENT

  
 Exhibit 10.61

  
 REGISTRATION RIGHTS AGREEMENT 
  
 This Registration Rights Agreement (this “Agreement”), dated as of
February 14, 2004, 2004, by and between VIISAGE TECHNOLOGY, INC., a Delaware corporation (the “Company”), and B. G. BECK, a Virginia resident (the “Stockholder”). 
  
 RECITALS 
  
 WHEREAS, the Company is a party to the Stock Purchase Agreement (the “Purchase Agreement”), dated February 14, 2004 (the “Closing
Date”), by and among the Company, Trans Digital Technologies Corporation, a Delaware corporation (“TDT”), and the Stockholder, pursuant to which the Stockholder will sell and transfer to the Company, and the Company will purchase, all
of the issued and outstanding securities of TDT and TDT will become a wholly owned subsidiary of the Company; 
  
 WHEREAS, pursuant to the Purchase Agreement, the Company agreed, among other things, to issue an aggregate of 5,850,000 shares (the “Original
Shares”) of common stock, $0.001 par value per share, of the Company (the “Common Stock”) to the Stockholder as part of the consideration to be paid pursuant to the Purchase Agreement; and 
  
 WHEREAS, it is a condition to the obligations of the Company and the
Stockholder under the Purchase Agreement that this Agreement be executed by the parties hereto, and the parties are willing to execute this Agreement and to be bound by the provisions hereof. 
  
 NOW, THEREFORE, in consideration of the foregoing, the agreements set forth
below, and the parties’ desire to further the interests of the Company and its present and future stockholders, the parties hereby agree with each other as follows: 
  
 1. Certain Defined Terms. As used in this Agreement, the following terms shall have the following respective
meanings: 
  
 (a) “Board” means the
Board of Directors of the Company. 
  
 (b)
“Commission” means the Securities and Exchange Commission or any other federal agency at the time administering the Securities Act. 
  
 (c) “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission
thereunder. 
  
 (d) “Holders” means the
Stockholder and any Permitted Transferees. 
  
 (e) “Person” means a corporation, an association, a partnership, an organization, a business, an individual, a governmental or political subdivision thereof or a governmental agency. 
  
 (f) “Registrable Securities” means the Original
Shares and any Common Stock and other securities of the Company issued or issuable with respect to any Original Shares by way of stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or
other reorganization or otherwise. As to any particular Registrable Securities, once issued such securities shall cease to be Registrable Securities when (i) any registration statement with respect to the sale of such securities shall have become
effective under the Securities Act, (ii) they shall have become eligible for sale to the public pursuant to Rule 144 (or any successor provision) under the Securities Act, (iii) they shall have been sold or otherwise transferred to any Person other
than a Permitted Transferee, or (iv) they shall have ceased to be outstanding. 
  
 (g) “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder.

  

 A-1 

 (h) “Shares” means and includes all Original Shares and any shares of Stock
hereafter acquired by the Stockholder (or any Permitted Transferee). 
  
 (i) “Stock” shall mean and include all shares of Common Stock and all other securities of the Company which may be issued in exchange for or in respect of shares of Common Stock (whether by way of stock
split, stock dividend, combination, reclassification, reorganization, or any other means). 
  
 2. Registration Requirements. 
  
 2.1 Shelf Registration. 
  
 (a)
Subject to Section 2.1(b), as soon as reasonably practicable after the Closing Date, the Company shall (i) file with the Commission a registration statement (the “Registration Statement”) on Form S-3 (or a successor form) covering the
resale to the public by the Holders of the Registrable Securities, and (ii) use commercially reasonable efforts to cause such Registration Statement to be declared effective as soon as practicable after the filing thereof with the Commission. Except
as otherwise expressly provided herein, the Company shall maintain the effectiveness of the Registration Statement until the earlier of (A) two (2) years from the date the Registration Statement is declared effective, or (B) such date on which all
of the Registrable Securities registered thereunder have been sold. 
  
 (b) Notwithstanding the provisions of this Section 2.1, the Company’s obligations to file the Registration Statement or cause such Registration Statement to become effective shall be suspended for such period,
not to exceed one hundred twenty (120) days, as the Company deems reasonably necessary if there is the occurrence or existence of any event, fact or pending corporate development (a “Corporate Development”) that, in the good faith
determination of the Board, makes it appropriate to suspend the Company’s obligations to file the Registration Statement and cause it to become effective. 
  

2.2 Registration Procedures. If and whenever the Company is required to effect the registration of the Registrable Securities in accordance with
Section 2.1, the Company shall: 
  
 (a) prepare
and file with the Commission an appropriate form of the Registration Statement and such amendments and supplements to the Registration Statement and the prospectus used in connection with the Registration Statement, and use commercially reasonable
efforts to cause the Registration Statement, and each such amendment and supplement, to become and remain effective, as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of the Registrable
Securities; 
  
 (b) furnish to the Holders such
reasonable number of copies of the prospectus, including the preliminary prospectus, Registration Statement, and any amendments (in each case, including all exhibits) in conformity with the requirements of the Securities Act, and such other
documents as the Holders may reasonably request in order to facilitate the disposition of Registrable Securities by them and otherwise comply with Section 2.3(c) below; 
  
 (c) use commercially reasonable efforts to register or qualify the Registrable Securities under the
securities or blue sky laws of such states and jurisdictions as shall be reasonably requested by the Holders, to cause all Registrable Securities to be registered with or approved by such other governmental agencies or authorities as may be
necessary to enable the Holders to consummate the transfer or disposition of Registrable Securities, to keep such registrations or qualifications in effect for so long as the Registration Statement remains in effect and do any and all other acts and
things that may be necessary to enable the Holders to consummate the transfer or disposition in such states and jurisdictions of the Registrable Securities owned by the Holders, including the removal of legends from certificates registered pursuant
to the Registration Statement (and to the end of removing the legend from certificates, if the Company is required to do so by the Company’s transfer agent and the facts underlying the sale are made available to the Company’s counsel by
way of representations reasonably acceptable to such counsel, the Company shall deliver to its transfer agent an opinion of counsel in form and substance reasonably acceptable to the transfer agent and reasonably capable of being given by such
counsel (with a copy to such Holder)); except that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or file a general consent to service of process in any such state or jurisdiction;

  

 A-2 

 (d) notify each Holder, at any time when a prospectus relating thereto covered by such
Registration Statement is required to be delivered under the Securities Act while the Registrable Securities are subject to this Agreement, of (i) the issuance by the Commission or any state or other jurisdiction of a stop order suspending the
effectiveness of the Registration Statement or the initiation of proceedings with respect to the Registration Statement under Section 8(d) or 8(e) of the Securities Act, (ii) the occurrence of any event or the existence of any fact (a “Material
Event”) as a result of which the Registration Statement shall contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading, or any
prospectus shall contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not
misleading, or (iii) the occurrence or existence of a Corporate Development that, in the good faith determination of the Board, makes it appropriate to suspend the availability of the Registration Statement and the related prospectus. Upon the
occurrence of any of clause (i), (ii), or (iii) above, then the Company shall, as promptly as is reasonably practicable, (A) in the case of clause (ii) above, prepare and file a post-effective amendment to the Registration Statement or a supplement
to the related prospectus or any document incorporated therein by reference or file any other required document that would be incorporated by reference into such Registration Statement and prospectus so that the Registration Statement does not
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading, and such prospectus does not contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, as thereafter delivered to the purchasers of the Registrable
Securities being sold thereunder, and, in the case of a post-effective amendment to the Registration Statement, use all commercially reasonable efforts to cause it to be declared effective as promptly as is reasonably practicable, and (B) give
notice to the Holders of any Registrable Securities that the availability of the Registration Statement is suspended (a “Deferral Notice”) and, upon receipt of any Deferral Notice, each Holder shall cease making offers and sales of any
Registrable Securities pursuant to the Registration Statement and the prospectus until such Holder’s receipt of copies of the supplemented or amended Registration Statement and prospectus provided for in clause (A) above, or until it is advised
in writing by the Company that the Registration Statement and prospectus may be used, and has received copies of any additional or supplemental filings that are incorporated or deemed incorporated by reference in the Registration Statement and
prospectus. Notwithstanding the foregoing, the Company will use commercially reasonable efforts to ensure that offers and sales of Registrable Securities under the Registration Statement and prospectus may be resumed (x) in the case of clause (i)
above, as promptly as is practicable, (y) in the case of clause (ii) above, as soon as, in the good faith determination of the Board, public disclosure of such Material Event would not be prejudicial to or contrary to the interests of the Company
or, if necessary to avoid unreasonable burden or expense, as soon as reasonably practicable thereafter and (z) in the case of clause (iii) above, as soon as, in the good faith determination of the Board, such suspension is no longer appropriate, but
in no event longer than one hundred twenty (120) days after delivery of the Deferral Notice; 
  
 (e) promptly apply for listing and list the Registrable Securities on the National Association of Securities Dealers Automatic Quotation
System or any national securities exchange or other automated interdealer quotation system on which a class of the Company’s equity securities is listed; 
  

(f) promptly notify the Holders: (i) when the Registration Statement, the prospectus or any prospectus supplement related thereto or
post-effective amendment to the Registration Statement has been filed, and, with respect to the Registration Statement or any post-effective amendment thereto, when the same has become effective; (ii) of any request by the Commission for amendments
or supplements to the Registration Statement or any prospectus or for additional information; (iii) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings
by any Person for that purpose; and (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification of any Registrable Securities for sale under the securities or blue sky laws of any jurisdiction or the
initiation or threat of any proceeding for such purpose; 
  
 (g) cooperate with the Holders to facilitate the timely preparation and delivery of certificates (not bearing any restrictive legends) representing the securities to be sold under the Registration Statement, and
enable such securities to be in such denominations and registered in such names as the Holders may reasonably request; 
  
 (h) in the event of the issuance of any stop order of which the Company or its counsel is aware or should be aware suspending the
effectiveness of any Registration Statement or any order suspending or preventing the use of any related prospectus or suspending the registration or qualification of any Registrable 

  

 A-3 

 
Securities for sale in any jurisdiction, the Company promptly will use commercially reasonable efforts to obtain its withdrawal; and 
  
 (i) provide the Holders and their counsel and accountants,
the opportunity to participate (by delivery of written comments to the Company) in the preparation of the Registration Statement, each prospectus included therein or filed with the Commission, and each amendment thereof or supplement thereto.

  
 2.3 Requirements of Holders. 
  
 (a) It shall be a condition precedent to the obligations of
the Company to take any action pursuant to this Article 2 in respect of the Registrable Securities of any selling Holder that such selling Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it,
and the intended method of disposition of such Registrable Securities as shall be required to effect the registration of such Registrable Securities. To the extent a Holder fails to provide such information in a timely manner, and if the Company
determines it appropriate and reasonable, the Company may either (i) delay the filing of the Registration Statement until the Holder provides such information, or (ii) upon the written request of Holders holding a majority of the Registrable
Securities, exclude the Registrable Securities held by such Holder from registration under the Registration Statement. 
  
 (b) No Holder shall distribute any prospectus or make any offer to sell (or solicit any offer to purchase) or sell any Registrable
Securities in a transaction covered by the Registration Statement and any prospectus thereunder from and after the time that the Company delivers a Deferral Notice to such Holder until such time as such Holder may resume offers and sales of
Registrable Securities under Section 2.2(d). 
  
 (c) Each Holder shall comply with the prospectus delivery requirements of the Securities Act in connection with offers to sell, solicitations of offers to purchase, and sales of Registrable Securities in connection with any offer or sale
pursuant to the Registration Statement. 
  
 2.4 Expenses of
Registration. In connection with the registration, filing or qualification of Registrable Securities pursuant to this Agreement, the Company shall pay the following expenses incurred in connection with such registration: (a) all registration and
filing fees with the Commission and National Association of Securities Dealers, Inc., (b) all fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel in connection with blue sky
qualifications of the Registrable Securities), (c) all printing, messenger and delivery expenses, (d) all fees and expenses incurred in connection with the listing or quotation of the Registrable Securities, (e) all fees and expenses of counsel to
the Company and its independent certified public accountants (including fees and expenses associated with the certified audits or the delivery of comfort letters), (f) all fees and expenses of any additional experts retained by the Company in
connection with such registration, and (g) all compensation of regular employees of the Company. The Holders shall pay any underwriting fees, discounts or commissions attributable to the sale of Registrable Securities and any out-of-pocket expenses
of the Holders and fees and expenses of their counsel. 
  
 2.5
Indemnification. 
  
 (a) The Company shall
indemnify and hold harmless each selling Holder, the officers, directors, partners, agents and employees of each selling Holder, any underwriter (as defined in the Securities Act) for such Holder and each Person, if any, who controls such selling
Holder or underwriter within the meaning of the Securities Act or the Exchange Act and their agents (collectively, the “Holder Indemnitees”), against any losses, claims, damages or liabilities (joint or several) to which they or any of
them may become subject under the Securities Act, the Exchange Act or any other federal or state law, including any amount paid in settlement of any litigation, commenced or threatened, and to reimburse them for any reasonable legal or other
expenses incurred by them, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (A) any untrue statement or alleged untrue statement of a material fact contained in the Registration
Statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto; (B) the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances in which they were made, not misleading; or (C) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any state securities law or any rule or regulation
promulgated under the Securities Act, the Exchange Act or any state securities law in connection with any matter relating to the Registration Statement (each, a “Violation”); provided, however, the indemnity agreement contained in
this Section 2.5(a) shall not (i) apply to any loss, claim, damage, liability or action 

  

 A-4 

 
arising out of, or based upon, a Violation which occurs in reliance upon and in conformity with written information furnished by any Holder; or (ii) in the
case of a sale directly by a Holder (including a sale of such Registrable Securities through any underwriter retained by such Holder engaging in a distribution solely on behalf of such Holder), inure to the benefit of any Person to the extent that
any such loss, claim, damage, liability or action results from an untrue statement or alleged untrue statement or omission or alleged omission that was contained in a preliminary prospectus and corrected in a final or amended prospectus, and such
Holder failed to deliver a copy of the final or amended prospectus at or prior to the confirmation of the sale of the Registrable Securities to the Person asserting any such loss, claim, damage or liability in any case in which such delivery is
required by the Securities Act. 
  
 (b) Each
Holder shall indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the Registration Statement, each Person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act,
each agent and any underwriter for the Company, and any other selling Holder or other stockholder selling securities in such Registration Statement or any of its directors, officers, partners, agents or employees or any Person who controls such
selling Holder or such other stockholder or such underwriter (collectively, the “Company Indemnitees”) against any losses, claims, damages or liabilities (joint or several) to which any Company Indemnitee may become subject under the
Securities Act, the Exchange Act or other federal or state law, including any amount paid in settlement of any litigation, commenced or threatened, and to reimburse them for any reasonable legal or other expenses incurred by them, insofar as such
losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written
information furnished by or on behalf of such selling Holder expressly for use in connection with such registration; provided, however, that the indemnity agreement contained in this Section 2.5(b) shall not, in the case of a sale directly by the
Company of its securities (including a sale of such securities through any underwriter retained by the Company to engage in a distribution solely on behalf of the Company), inure to the benefit of any Person to the extent that any such loss, claim,
damage, liability or action results from an untrue statement or alleged untrue statement or omission or alleged omission that was contained in a preliminary prospectus and corrected in a final or amended prospectus, and the Company failed to deliver
a copy of the final or amended prospectus at or prior to the confirmation of the sale of the securities to the Person asserting any such loss, claim, damage or liability in any case in which such delivery is required by the Securities Act.

  
 (c) Promptly after receipt by any Company
Indemnitee or Holder Indemnitee (collectively, the “Indemnitees”) under this Section 2.5 of notice of the commencement of any action (including any governmental action), such Indemnitee will, if a claim in respect thereof is to be made
against any indemnifying party under this Section 2.5, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so
desires, jointly with any other indemnifying party similarly noticed, to assume and control the defense thereof with counsel mutually satisfactory to the parties; provided, however, that such Indemnitee shall have the right to retain its own
counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such Indemnitee by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests, as reasonably
determined by either party, between such Indemnitee and any other party represented by such counsel in such proceeding. In no event shall the Indemnitees be entitled to more than one firm of counsel at the expense of the indemnifying party. The
failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if materially prejudicial to its ability to defend such action, shall relieve such indemnifying party of any liability to
the Indemnitee under this Section 2.5 to the extent of such prejudice, but the omission to so deliver written notice to the indemnifying party will not relieve it of any liability that it may have to such Indemnitee otherwise than under this Section
2.5. If the indemnifying party advises an Indemnitee that it will contest a claim for indemnification hereunder, or fails, within 30 days of receipt of any indemnification notice to notify, in writing, such Indemnitee of its election to defend,
settle or compromise, at its sole cost and expense, any action, proceeding or claim (or discontinues its defense at any time after it commences such defense), then the Indemnitee may, at its option, defend, settle or otherwise compromise or pay such
action or claim in each case at the indemnifying party’s expense. In any event, unless and until the indemnifying party elects in writing to assume and does so assume the defense of any such claim, proceeding or action, the Indemnitee’s
reasonable costs and expenses arising out of the defense, settlement or compromise of any such action, claim or proceeding shall be losses subject to indemnification hereunder. The Indemnitee shall cooperate fully with the indemnifying party in
connection with any negotiation or defense of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Indemnitee that relates to such action or claim. The
indemnifying party shall keep the Indemnitee fully informed at all times as to the status of the defense or any settlement negotiations with respect thereto. If the indemnifying party elects not to defend any such action or claim, 

  

 A-5 

 
the Indemnitee party shall keep the indemnifying party informed at all times as to the status of the defense; provided, however, that the failure to
keep the indemnifying party so informed shall not affect the obligations of the indemnifying party hereunder. No indemnifying party shall be liable for any settlement of any action, claim or proceeding effected without its written consent;
provided, however, that the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the written consent of the Indemnitee, consent to entry of any judgment or enter into any
settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnitee of a general written release from all liability with respect to such claim or litigation. 
  
 (d) The obligations of the Company and the Holders under
this Section 2.5 shall survive the completion of any offering of Registrable Securities in a Registration Statement whether under this Article 2 or otherwise. 
  

(e) If the indemnification provided for in this Section 2.5 is unavailable to a party that would have been an Indemnitee under this
Section 2.5 in respect of any losses, claims, damages or liabilities (or actions or proceedings in respect thereof) referred to herein, then each party that would have been an indemnifying party hereunder shall, in lieu of indemnifying such
Indemnitee, contribute to the amount paid or payable by such Indemnitee as a result of such losses, claims, damages or liabilities (or actions or proceedings in respect thereof) in such proportion as is appropriate to reflect the relative fault of
such indemnifying party, on the one hand, and such Indemnitee, on the other hand, in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities (or actions or proceedings in respect thereof). The
relative fault shall be determined by reference to, among other things, whether the Violation relates to information supplied by such indemnifying party or such Indemnitee and the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent such Violation. The parties agree that it would not be just and equitable if contribution pursuant to this Section 2.5(e) were determined by pro rata allocation or by any other method of allocation which does not
take account of the equitable considerations referred to in the preceding sentence. The amount paid or payable by a contributing party as a result of the losses, claims, damages or liabilities (or actions or proceedings in respect thereof) referred
to above in this Section 2.5(e) shall include any legal or other expenses reasonably incurred by such Indemnitee in connection with investigating or defending any such action or claim. No Person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. 
  
 (f) The indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of an
Indemnitee against an indemnifying party or others and (ii) any liabilities the indemnifying party may be subject to pursuant to applicable law. 
  
 2.6 Reports Under the Exchange Act. With a view to making available to the Holders the benefits of Rule 144 promulgated under the Securities Act
(“Rule 144”) and any other rule or regulation of the Commission that may at any time permit a Holder to sell securities of the Company to the public without registration, the Company agrees to use commercially reasonable efforts:

  
 (a) to file with the Commission in a timely
manner all reports and other documents required of the Company under the Exchange Act and the rules and regulations promulgated thereunder; 
  
 (b) if not required to file such reports and documents referred to in subsection (a) above, to keep publicly available certain information
regarding the Company, as contemplated by Rule 144(c)(2) of the Securities Act; and 
  
 (c) to take all other actions reasonably necessary to enable a Holder to sell the Registrable Securities without registration under the
Securities Act within the limitation of the exemption provided by Rule 144. 
  
 3. Lock-up Agreement. 
  
 3.1 Lock-up. Subject to the terms of that certain Letter Agreement dated February 14, 2004 by and among the Company, the Stockholder and Lau Technologies, the Stockholder hereby agrees that, during the period beginning from the date
of this Agreement until the date that is one (1) year after the Closing Date, such Holder will not, without the prior written consent of the Company, directly or indirectly, (a) offer, sell, contract to sell, assign, transfer, encumber, pledge,
grant any option to purchase, make any short sale or otherwise dispose of any of the Shares, (b) enter into or establish any arrangement constituting a “put equivalent position,” as defined by Rule 16a-1(h) 

  

 A-6 

 
promulgated under the Exchange Act, (c) enter into any swap or other arrangement that transfers all or a portion of the economic consequences associated with
the ownership of any Shares, (d) except as expressly permitted by this Agreement, exercise any registration rights with respect to any Shares, or (e) announce an intent to do any of the forgoing. 
  
 3.2 Permitted Transfers. Notwithstanding the foregoing, a Holder may
transfer any Shares to a Permitted Transferee in accordance with Section 7. 
  
 3.3 Specific Enforcement. The Stockholder expressly agrees that the Company will be irreparably damaged if this Article 3 is not specifically enforced. Upon a breach or threatened breach of the terms, covenants
and/or conditions of this Article 3 by the Stockholder (or any Permitted Transferee), then the Company shall, in addition to all other remedies, be entitled to seek a temporary or permanent injunction, without showing any actual damage, and/or a
decree for specific performance, in accordance with the provisions hereof. 
  
 4. Legends. Each certificate evidencing any of the Registrable Securities shall bear a legend substantially as follows: 
  

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER SET FORTH IN THAT CERTAIN REGISTRATION RIGHTS
AGREEMENT, A COPY OF WHICH THE COMPANY WILL FURNISH TO THE HOLDER OF THIS CERTIFICATE UPON REQUEST AND WITHOUT CHARGE.” 
  
 In addition, each certificate evidencing any of the Original Shares shall bear a legend substantially as follows: 
  
 “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR AN OPINION OF COUNSEL, IN FORM, SUBSTANCE
AND SCOPE REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.” 
  
 The Company agrees to take such necessary steps to remove the foregoing legends upon request by the Holders and upon receipt from the Holders of
appropriate documents, including an opinion of counsel reasonably acceptable to the Company, to support the request for such removal. 
  
 5. Notices. All notices, requests and other communications hereunder must be in writing and will be deemed to have been duly given only if
delivered personally or by facsimile transmission against facsimile confirmation or mailed by a nationally recognized overnight courier prepaid, to the parties at the following addresses or facsimile numbers: 
  
 If to the Company to: 
  
 Viisage Technology, Inc. 
 30 Porter Road 
 Littleton, Massachusetts
01460 
 Facsimile No.: (978) 952.2225 
 Attn: Bernard C. Bailey, President 
  
 with a copy
(which shall not constitute notice) to: 
  
 Venable LLP

 8010 Towers Crescent Drive, Suite 300 
 Vienna, Virginia 22182 
 Facsimile No.: (703) 821-8949 
 Attn: Joseph C. Schmelter, Esq. 
  

 A-7 

 If to the Stockholder: 
  
 c/o Trans Digital Technologies Corporation 
 1215 Jefferson Davis Highway 
 Suite 1105 
 Arlington, Virginia 22202 
 Facsimile No.:
(703) 414.5835 
  
 with a copy (which shall not constitute
notice) to: 
  
 Williams Mullen 
 1666 K Street, N.W., Suite 1200 
 Washington,
D.C. 20006 
 Facsimile No.: (202) 293-5939 
 Attn: James A. Blalock, III, Esq. 
  
 Or in the
case of any Permitted Transferee, to the address and/or facsimile number such Permitted Transferee shall have provided to the Company in writing. 
  
 All such notices, requests and other communications will (a) if delivered personally to the address as provided in this Section 5, be deemed given upon
delivery, (b) if delivered by facsimile transmission to the facsimile number as provided for in this Section 5, be deemed given upon facsimile confirmation, and (c) if delivered by overnight courier to the address as provided in this Section 5, be
deemed given on the earlier of the first business day following the date sent by such overnight courier or upon receipt (in each case regardless of whether such notice, request or other communication is received by any other person to whom a copy of
such notice is to be delivered pursuant to this Section 5). Any party from time to time may change its address, facsimile number or other information for the purpose of notices to that party by giving notice specifying such change to the other party
hereto. 
  
 6. Course of Dealing; Amendments, Waivers and
Consents. No course of dealing between the parties shall operate as a waiver of any party’s rights under this Agreement. Each party acknowledges that if any party, without being required to do so by this Agreement, gives any notice or
information to, or obtains any consent from, the other party, such party shall not by implication have amended, waived or modified any provision of this Agreement, or created any duty to give any such notice or information or to obtain any such
consent on any future occasion. No delay or omission on the part of any party in exercising any right under this Agreement shall operate as a waiver of such right or any other right hereunder or thereunder. A waiver on any one occasion shall not be
construed as a bar to or waiver of any right or remedy on any future occasion. No amendment, waiver or consent with respect to this Agreement shall be binding unless it is in writing and signed by each of the Company and the Holders of a majority of
the Registrable Securities. 
  
 7. Assignment. This
Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and each of their respective successors and assigns; provided, however, that the rights of the Stockholder under this Agreement shall
not inure to the benefit of and be enforceable by any successor or assignee of the Stockholder other than any successor or assignee that is controlled by, under common control with, or controls the Stockholder or who is a member of the
“immediate family” (as such term is defined under Rule 16a-1(e) promulgated by the Commission under the Exchange Act) of the Stockholder (a “Permitted Transferee”), provided, however, that any such Permitted
Transferee agrees in writing to be bound by the provisions of this Agreement to which the Stockholder is subject. 
  
 8. Descriptive Headings. The descriptive headings of the several sections and paragraphs of this Agreement are inserted for reference only and
shall not limit or otherwise affect the meaning hereof. 
  
 9.
Governing Law, Submission to Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware as applied to contracts entered into by Delaware residents and performed entirely in Delaware,
without giving effect to its principles or rules regarding conflicts of laws, other than such principles directing application of the laws of Delaware. Each party hereto irrevocably agrees that any legal action or proceeding with respect to this
Agreement or for recognition and enforcement of any judgment in respect hereof brought by another party hereto or its successors or assigns shall be brought and determined only by either a 

  

 A-8 

 
state court or federal court sitting in the Commonwealth of Massachusetts or the Commonwealth of Virginia and each party hereto hereby irrevocably submits
with regard to any such action or proceeding for itself and in respect to its property, generally and unconditionally, to the nonexclusive jurisdiction of the aforesaid courts. Each party hereto hereby irrevocably waives, and agrees not to assert,
by way of motion, as a defense, counter claim or otherwise, in any action or proceeding with respect to this Agreement, (a) any claim that it is not personally subject to the jurisdiction of the above-named courts for any reason other than the
failure to serve process in accordance with this Section 9, (b) that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior
to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise), and (c) to the fullest extent permitted by applicable law, that (i) the suit, action or proceeding in any such court is brought in an inconvenient forum,
(ii) the venue of such suit, action or proceeding is improper and (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such courts. Without limitation of the foregoing, no party shall have the right to request or demand
that any legal action or proceeding brought by another party in Massachusetts be transferred to Virginia or vice versa. 
  
 10. WAIVER OF TRIAL BY JURY. IN ANY ACTION OR PROCEEDING ARISING HEREFROM, THE PARTIES HERETO CONSENT TO TRIAL WITHOUT A JURY IN ANY ACTION,
PROCEEDING OR COUNTERCLAIM BROUGHT BY ANY PARTY HERETO AGAINST THE OTHER OR THEIR SUCCESSORS IN RESPECT OF ANY MATTER ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, REGARDLESS OF THE FORM OF ACTION OR PROCEEDING. 
  
 11. Counterparts. This Agreement may be executed simultaneously in any
number of counterparts, each of which shall be deemed an original, but all such counterparts shall together constitute one and the same instrument. 
  
 12. Entire Agreement. This Agreement, along with that certain side letter agreement dated February 14, 2003, by and among BGB, Parent and Lau
Technologies, embodies the entire agreement and understanding between the Company and each other party hereto relating to the subject matter hereof and supersedes all prior agreements and understandings relating to such subject matter. 

 
 13. Severability. If any provision of this Agreement, or the
application of such provisions to any party or circumstance, shall be held invalid, the remainder of this Agreement, or the application of such provision to the parties or circumstances other than those to which it is held invalid, shall not be
affected thereby. 
  
 IN WITNESS WHEREOF, the parties have caused
this Agreement to be executed and delivered as of the date first above written. 
  

					
	COMPANY:
	
	 VIISAGE TECHNOLOGY, INC.

		
	By:	 	/s/    BERNARD C.
BAILEY        
	 	 	 Name:
	 	Bernard C. Bailey
	 	 	 Title:
	 	President
	
	STOCKHOLDER:
	
	/s/    B.G. BECK        
	B. G. Beck

  

 A-9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00075-of-00352.parquet"}]]